Inflammation of the thyroid characterised by a triphasic course of transient thyrotoxicosis, followed by hypothyroidism, followed by a return to euthyroidism.
The thyrotoxic phase is due to thyroid follicular damage and release of preformed hormone and is characterised by low thyroid uptake on nuclear scan and elevated ESR or CRP.
Thyroid pain and tenderness, which may be migratory and affect different areas of the gland at different times, is typical of the thyrotoxic phase. Thyroid is often enlarged, firm, and tender to palpation.
Ultrasound of the thyroid shows areas of hypoechoic echotexture with decreased or normal vascular flow by Doppler.
The condition is self-limited, and no specific therapy is generally necessary. Non-steroidal anti-inflammatory drugs and beta-blockers may be used for symptoms. Some patients with severe symptoms may also require corticosteroids, opioid analgesics, or potassium iodide or iopanoic acid to reduce the conversion of T4 to the more biologically active form of thyroid hormone, T3.
Subacute granulomatous thyroiditis is a self-limited inflammation of the thyroid gland. It is associated with a triphasic clinical course that lasts for a few weeks to many months, characterised by transient thyrotoxicosis, hypothyroidism, and then a return to normal thyroid function in >90% of patients. The initial thyrotoxic phase is associated with thyroid pain, high serum thyroid hormone levels with a low radioiodine uptake, elevated ESR, elevated CRP, and a systemic illness similar to influenza, with fever, myalgia, and malaise.
History and exam
Stephanie L. Lee, MD, PhD
Director of the Thyroid Health Center
Section of Endocrinology, Diabetes and Nutrition
Boston Medical Center
Associate Professor of Medicine
Boston University School of Medicine
SLL declares that she has no competing interests.
Georg Hennemann, MD
Professor of Medicine and Endocrinology
Medical Center Spijkenisse
Ronald Merrell, MD
Professor of Surgery
Virginia Commonwealth University
RM declares that he has no competing interests.
Jim Stockigt, MD, FRACP, FRCPA
Epworth and Alfred Hospitals
Professor of Medicine
At the time of review, JS declared that he had no competing interests. Unfortunately, we have since been made aware that JS is deceased.
Use of this content is subject to our disclaimer